Evidence map›Paper›PMID 33833942›Full record

ReviewGlobal heart2021

SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.

Okechukwu S Ogah, Ejiroghene M Umuerri, Adewole Adebiyi, Olanike A Orimolade, Mahmoud U Sani, Dike B Ojji, Amam C Mbakwem, Simon Stewart, Karen Sliwa

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Global heart, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 11 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

Okechukwu S OgahDepartment of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Nigeria/Department of Medicine, University College Hospital Ibadan, NG.
Ejiroghene M UmuerriDepartment of Medicine, Delta State University, Abraka, Delta State Nigeria/Department of Medicine, Delta State University Teaching Hospital, Oghara, Delta State, NG.
Adewole AdebiyiDepartment of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Nigeria/Department of Medicine, University College Hospital Ibadan, NG.
Olanike A OrimoladeDepartment of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Nigeria/Department of Medicine, University College Hospital Ibadan, NG.
Mahmoud U SaniDepartment of Medicine Bayero University Kano & Aminu Kano University Teaching Hospital, Kano, NG.
Dike B OjjiDepartment of Medicine, University of Abuja, Abuja, Nigeria/Department of Medicine, University of Abuja Teaching Hospital, Abuja, NG.
Amam C MbakwemDepartment of Medicine, University of Lagos, Akoka, Lagos, Nigeria/Department of Medicine, Lagos University Teaching Hospital, Idi-araba, Lagos, NG.
Simon StewartTorrens University Australia, Adelaide, South Australia, AU.
Karen SliwaHatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, ZA.
University of Cape Town · ZABayero University Kano · NGDelta State University · NGLagos University Teaching Hospital · NGTorrens University Australia · AUUniversity College Hospital, Ibadan · NGUniversity of Abuja · NGUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current pandemic of SARS-COV 2 infection (Covid-19) is challenging health systems and communities worldwide. At the individual level, the main biological system involved in Covid-19 is the respiratory system. Respiratory complications range from mild flu-like illness symptoms to a fatal respiratory distress syndrome or a severe and fulminant pneumonia. Critically, the presence of a pre-existing cardiovascular disease or its risk factors, such as hypertension or type II diabetes mellitus, increases the chance of having severe complications (including death) if infected by the virus. In addition, the infection can worsen an existing cardiovascular disease or precipitate new ones. This paper presents a contemporary review of cardiovascular complications of Covid-19. It also specifically examines the impact of the disease on those already vulnerable and on the poorly resourced health systems of Africa as well as the potential broader consequences on the socio-economic health of this region.

Indexed as

Acute Coronary SyndromeAfricaAntimalarialsArrhythmias, CardiacCardiovascular DiseasesChloroquineCoronavirus InfectionsCOVID-19Delivery of Health CareEconomic FactorsEconomic RecessionGross Domestic ProductHealth ResourcesHeart FailureHumansHydroxychloroquineAntimalarialsChloroquineHydroxychloroquineAfricaArrhythmiasCardiovascular diseaseCovid-19health systemHeart disease, Cardiac diseaseHeart failureMyocarditisSARS CoV-2socio-economic

Identifiers

PMID33833942
PMCPMC7977038
OpenAlexW3138503838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.